- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Genzyme Dropping Because of FDA Warning (GENZ)
Recent Articles by Benzinga Staff
- Biotech Stock Mailbag: Generex (PFE, MNKD)
- Apple Is Hoping To Have Apps For That (AAPL)
- Potential Reversals 3/19/10
- Coal Prices Ready To Burn Hot In 2010?
- Stifel Nicolaus Still Gives TriQuint A Buy (TQNT)
Company News
- Tiffany Reports Earnings Monday Morning (TIF)
- Carl Icahn Makes Hostile Takeover Bid For Lions Gate Entertainment (LGF)
- Ex-Cadbury Executive To Head Kraft’s Confectionery Unit (KFT)
- Morningstar Acquires Realpoint LLC (MORN)
- Pfizer Eyes German Drug Maker Stada (PFE, TEVA)
Movers
- Energy ETF Under Pressure (XLE)
- Healthcare ETF Close To Going Green (XLV)
- Teva Pharmaceutical Moving On High Volume Again (TEVA)
- Bear Flag On Chart Looks Promising..But Volume Could Stall It. (NASDAQ:QQQQ), (NYSE:SPY), (NYSE:DIA)
- Benzinga’s Volume Movers (CTEL, IPSU, HANS, TEVA, TRMB)
FDA
Posted on 11/13/09 at 12:52pm by Benzinga Staff
The US FDA is warning doctors about potential for foreign particle contamination of several rare drug diseases manufactured by Genzyme (Nasdaq: GENZ).
Genzyme is trading down 7.5% to $49.18.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
